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Abstract Cornus mas L. (CM) fruits are rich in antho-
cyanins and possess both antiinflammatory and antioxidant
activities. The current study was conducted to investigate
whether supplementation with CM could ameliorate lipid
profile and vascular inflammation in dyslipidemic children
and adolescents. In this randomized clinical trial, 40 dy-
slipidemic children and adolescents ages 9 to 16 years
were assigned to receive 50 g of CM twice a day after
lunch and dinner (n = 20, case group) or to continue their
normal diet (n = 20, control group). The serum levels of
total cholesterol (TC), low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C),
triglycerides (TG), apo A-I, apo B, intracellular adhesion
molecule-1 (ICAM-1), vascular cell adhesion molecule-1
(VCAM-1), C-reactive protein (CRP), and anthropometric
indices were determined at baseline and then after weeks 3
and 6 of the trial. After week 6 of the trial, the TC, TG,
LDL-C, apo B, ICAM-1, and VCAM-1 levels in the CM
group were significantly lower and the HDL-C and apo A-I
levels higher than at baseline. After week 6 of the trial,
none of these parameters in the control group, except for
ICAM-1, was significantly altered from baseline. However,
between-group comparison showed a significant difference
only for apo A-I (p = 0.016) and a borderline significant
difference for ICAM-1 (p = 0.076). No significant differ-
ence in body mass index, waist-to-hip ratio, or C-reactive
protein was observed between the studied groups. The
present findings revealed a trend toward amelioration of
lipid profile and vascular inflammation following addition
of CM to the daily diet of dyslipidemic children and ado-
lescents but this needs to be verified by larger scale trials.
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Introduction
The prevalence of dyslipidemia is increasing worldwide
[35], and this trend is closely associated with a rise in
atherothrombotic events such as cardiovascular and cere-
brovascular diseases. Both of these diseases are among the
leading causes of death and disability in industrialized
countries [15].
Atherosclerosis is the underlying cause of coronary
heart disease (CHD), which starts from childhood and
progresses over time in a chronic and silent fashion [24].
Observational studies have consistently indicated that
dyslipidemia can impair vascular integrity, structure, and
function in children [38]. Anatomic evidence from popu-
lation studies has shown that cardiovascular risk factors,
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when present in childhood, have a detrimental impact on
the vascular endothelium and accelerate disease progres-
sion during childhood and adulthood [19]. In most children,
atherosclerotic vascular changes are minor and can be
minimized or prevented with a healthy lifestyle [2].
The use of plants as medicines dates back to the earliest
years of human life. Consumption of fruits, particularly
those with higher contents of phenolics and flavonoids, has
been shown to ameliorate lipid profile status and to be
inversely associated with the incidence of cardiovascular
disease [23, 44]. Fruits of the Cornelian cherry (Cornus
mas L. [CM]) are characterized by a high nutritional value
[1]. Moreover, CM has been used in the traditional medi-
cine of the Caucasus and Central Asia for more than
1,000 years. Traditional applications of CM include treat-
ment of diarrhea, inflammatory bowel disease, fever,
malaria, kidney stones, urinary tract infections, cancer, and
sunstroke [43].
Cornus mas L. is a rich source of several bioactive
phytochemicals including anthocyanins, ursolic acid, and
vitamin C [16, 33, 37, 39]. Anthocyanins such as cyanidin,
malvidin, peonidin, pelargonidin, and petunidin are
endowed with a multitude of pharmacologic properties
including lipid-lowering, antioxidant, anti-allergic, antiin-
flammatory, anticoagulant, and antidiabetic effects [3, 9,
12, 16, 37, 39]. Considering the rich content of anthocya-
nins and other phytochemicals with cardioprotective,
antiinflammatory, and lipid-lowering properties in CM, this
plant can potentially ameliorate dyslipidemia and vascular
inflammation. The current study was undertaken to verify
this hypothesis in a randomized trial among dyslipidemic
children and adolescents.
Methods
Participants
This randomized clinical trial was designed to evaluate the
antidyslipidemic and antiinflammatory effects of CM on
children. The study, conducted in 2011, recruited 40 dy-
slipidemic children ranging in age from 9 to 16 years. The
participants were randomly selected from those referred to
the Pediatric Preventive Cardiology Department of the
Isfahan Cardiovascular Research Center affiliated within the
Isfahan University of Medical Sciences (Isfahan, Iran). The
allocation was conducted with computer-generated random
numbers using the participants’ record numbers in the clinic.
The inclusion criteria were patients 9 to 16 years of age
who had at least one of the following dyslipidemic mea-
sures: serum TG C 150 mg/dL, TC C 170 mg/dL, LDL-
C C 130 mg/dL or HDL-C \ 35 mg/dL. The exclusion
criteria ruled out the use of medications altering lipid
metabolism; subjects with known chronic diseases such as
diabetes mellitus, nephrotic syndrome, and chronic pan-
creatitis; and liver, thyroid, and bile duct disorders.
The demographic and medical histories were taken from
the reports of participants and their parents. The study
protocol was approved by the Medical Ethics Committee of
the Isfahan Cardiovascular Research Center under approval
no. 89108.
Study Design
Cornus mas L. fresh fruits were purchased from a local
fruit market in Isfahan, Iran. The genus and species of each
plant were identified and authenticated by a plant taxono-
mist and deposited with the herbarium code of 093/001/001
at the Isfahan Department of Natural Resources.
The participants were randomized into two groups of equal
size (n = 20). The participates in the two groups were mat-
ched for age, sex, height, and weight. Both groups received
similar advice on physical activity and diet during the course
of the study. The case group was administered 50 g of CM
twice a day after lunch and dinner for a period of 6 weeks.
Biochemical and Anthropometric Measurement
All measurements were made by a trained team of general
physicians and nurses under the supervision of the same
pediatrician. Anthropometric and biochemical measure-
ments were performed using calibrated instruments and
standard protocols at baseline and then after weeks 3 and 6
of the trial.
Fasting venous blood samples were collected from both
groups for measurement of the biochemical factors. Serum
total cholesterol (TC), triglyceride (TG), and high-density
lipoprotein cholesterol (HDL-C) levels were assayed using
Pars Azmoon kits (Iran) on a Hitachi auto-analyzer (Japan).
Low-density lipoprotein cholesterol (LDL-C) values were
calculated according to the Friedewald formula [11]. Apo-
lipoproteins (apo A-I and apo B) and C-reactive protein
(CRP) concentrations were determined using Pars Azmoon
kits (Pars Azmoon Co., Tehran, Iran) on an automated
chemistry analyzer (Hitachi model 902) (Hitachi Ltd.,
Tokyo, Japan) and based on a turbidimetric method. Serum
concentrations of intercellular adhesion molecule-1 (ICAM-
1) and vascular cell adhesion molecule-1 (VCAM-1) were
determined using an enzyme-linked immunoassay (ELISA)
(Boster Biological Technology Ltd., Wuhan, China).
Waist circumference was determined from the point
halfway between the lower border of ribs and the iliac crest in
a horizontal plane. Body mass index (BMI) was calculated by
dividing weight (in kilograms) by height (in square meters),
and the waist-to-hip ratio (WHR) was calculated by dividing
waist circumference (cm) by height (in centimeters).
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Statistical Analysis
Data are expressed as means ± standard deviations. Sta-
tistical analyses were performed using SPSS program,
version 16.0 (SPSS, Chicago, IL, USA).Independent sam-
ples t-tests and paired samples t-tests were applied to
compare group means. The efficacy of CM to improve
anthropometric, lipid profile, and inflammatory factors was
assessed using repeated measures analysis of variance
(ANOVA). A p value lower than 0.05 was considered to be
statistically significant.
Results
Changes in anthropometric parameters (BMI and WHR)
during the 6-week course of the trial were comparable
between the CM and control groups (p [ 0.05) (Table 1).
Overall, there were significant reductions in TC, TG, and
LDL-C, and significant increases in HDL-C, HDL-C/TC,
and HDL-C/LDL-C from baseline to week 6 in the CM
group (p \ 0.05). The posttrial values for these parameters
after week 6 were statistically unchanged compared with
the baseline values in the control group (p [ 0.05).
Nonetheless, between-group differences did not reach sta-
tistical significance (p [ 0.05) (Table 2).
Similar to lipoproteins, analysis of apolipoproteins
showed a significant elevation of apo A-I and a decline in
apo B after CM consumption (p \ 0.05). However, the
magnitude of the changes reached statistical significance
only for apo A (p = 0.016) (Table 3).
With regard to the inflammatory biomarkers, significant
reductions in ICAM-1 and VCAM-1 were observed in the CM
group after week 6 compared with baseline (p \ 0.05),
whereas no significant alteration was observed for serum CRP
(p [ 0.05). The magnitude of the changes in the aforemen-
tioned parameters were not found to differ significantly
between the groups, although a trend toward superiority of
CM was observed for ICAM-1 (p = 0.076) (Table 4).
Discussion
Evidence from the current trial indicated a trend toward
improvement of the lipid profile (comprising LDL-C,
HDL-C, TC, TG, apo A-I, and apo B) and the vascular
inflammation biomarkers (ICAM-1 and VCAM-1) after
CM consumption. Although most of these parameters
remained statistically unchanged in the control group, we
failed to detect a significant between-group difference
between the studied arms. This issue could be attributable
to the relatively few recruited subjects and associated
limited power as well as the short supplementation
period.
Dyslipidemia is an important risk factor for cardiovas-
cular and cerebrovascular disease and associated compli-
cations [15]. Phenolics, particularly flavonoids, are natural
products that constitute an important part of the human diet
and are considered to be active constituents in many
medicinal plants [4, 8, 10, 18, 25, 28, 29, 32]. Hence, a
great deal of interest has been focused on identifying bio-
active flavonoids from natural sources to be exploited for
pharmacologic and medicinal properties.
A study by Rafieian-Kopaei et al. [30] found that daily
supplementation with 1 g/kg bodyweight of CM powder in
hypercholesterolemic rabbits for 60 days was associated
with a significant increase in the atherogenic index (log
TG/HDL) of plasma. Additionally, CM decreased TC,
LDL, and TG levels together with atherosclerotic lesion in
the aorta, although these reductions were not statistically
significant.
Anthocyanin-rich diets such as those containing cherries
show evidence of an impact on the modulation of dysli-
pidemia through reducing TC, TG, glucose, insulin, and
liver fat levels [7]. Seymour et al. [34] reported that cherry-
enriched diets significantly lowered plasma TC and TG
while slightly raising HDL-C and significantly elevating
plasma antioxidant capacity. The cherry-enriched diets also
showed an interesting antisteatotic effect due to the miti-
gation of TG and cholesterol accumulation in the liver.
Table 1 Effect of Cornus mas on body mass index (BMI) and waist-to-hip ratio (WHR) levels in experimental groups
Group Baseline Week 3 Week 6 Interaction p value
time 9 group
Group p value Time
p value
Mean BMI Control 24.07 ± 2.34 24.14 ± 2.39 24.30 ± 2.18a 0.253 0.513 0.624
Case 25.16 ± 4.56 25.05 ± 4.38 25.06 ± 4.49
p value 0.19 0.24 0.65
Mean WHR Control 0.91 ± 0.03 0.91 ± 0.03 0.91 ± 0.03 0.688 0.425 0.879
Case 0.92 ± 0.03 0.92 ± 0.03 0.92 ± 0.03
p value 0.69 0.74 0.43
a Significant difference versus baseline
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Xia et al. [40, 41], reported that diets of atherosclerosis-
prone mice supplemented with an anthocyanin-rich extract
from black rice significantly reduced atherosclerosis bur-
den, TC and TG concentrations, and tissue cholesterol
content while boosting HDL-C levels. According to
another study by Jayaprakasam et al. [16], anthocyanin-
treated mice exhibited reduced lipid accumulation in the
liver, which is particularly important for TG due to its key
role in triggering fatty liver disease.
Antioxidants reduce the activity of free radicals and
prevent lipid peroxidation [14]. It may be postulated that
the beneficial anti-atherosclerotic and antidyslipidemic
effects of CM are, at least in part, due to its antioxidant
activity [22]. Results by Safari and Sheikh [31] have
indicated that phenolic compounds such as quercetin found
in tart cherries protect LDL from oxidative damage, thus
reducing its atherogenicity. Flavonoids also can protect
endothelial cells against oxidative stress and inhibit the
Table 2 Effect of Cornus mas on lipid profile levels in experimental groups
Lipid profile Group Baseline Week 3 Week 6 Interaction
p value
time 9 group
Group
p value
Time
p value
Total cholesterol (TC) (mg/dL) Control 205.72 ± 34.75 208.83 ± 34.10 199.44 ± 34.95 0.033 0.599 0.001
Case 225.85 ± 56.02 211.85 ± 53.07a 197.14 ± 40.10a,b
p value 0.435 0.861 0.851
Triglyceride (TG) (mg/dL) Control 143.94 ± 49.16 198.61 ± 80.13a 154.27 ± 53.04b 0.057 0.100 0.006
Case 137.38 ± 46.51 140.14 ± 37.78 120.47 ± 50.56a,b
p value 0.416 0.005 0.049
Low-density lipoprotein
(LDL) (mg/dL)
Control 211.33 ± 38.58 205.05 ± 43.41 205.81 ± 42.09 0.234 0.559 0.015
Case 229.00 ± 57.28 212.45 ± 59.10a 206.20 ± 39.78a
p value 0.601 0.956 0.721
High-density lipoprotein
(HDL) (mg/dL)
Control 34.44 ± 14.74 35.94 ± 10.42 37.22 ± 11.03 0.166 0.397 0.003
Case 30.70 ± 12.07 30.30 ± 12.61 36.85 ± 14.51a,b
p value 0.170 0.054 0.891
HDL/TC Control 0.169 ± 0.07 0.174 ± 0.05 0.190 ± 0.06 0.089 0.343 0.000
Case 0.141 ± 0.06 0.147 ± 0.05 0.194 ± 0.06a,b
p value 0.124 0.049 0.829
HDL/LDL Control 0.161 ± 0.05 0.178 ± 0.05a 0.183 ± 0.05a 0.070
Case 0.136 ± 0.05 0.143 ± 0.04 0.179 ± 0.05a,b 0.180
p value 0.103 0.013 0.847 0.000
Values are expressed as mean ± standard deviation
a Significant difference versus baseline
b Significant difference versus 3rd week
Table 3 Effect of Cornus mas on apo lipoprotein A and B levels in experimental groups
Group Baseline Week 3 Week 6 Time 9 group
interaction p value
Group
p value
Time
p value
Apo A-I (mg/dL) Control 150.46 ± 13.12 146.26 ± 9.92a 142.46 ± 17.51 0.00 0.016 0.116
Case 151.33 ± 20.48 158.73 ± 15.03 168.93 ± 17.34a,b
p value 0.89 0.01 0.00
Apo B (mg/dL) Control 78.60 ± 22.48b 77.53 ± 22.66a 72.46 ± 23.86 0.26 0.619 0.001
Case 86.93 ± 27.48 78.80 ± 23.40 75.13 ± 19.89a
p value 0.371 0.881 0.742
Values are expressed as mean ± standard deviation
a Significant difference versus baseline
b Significant difference versus 3rd week
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proinflammatory response that usually underlies the pro-
cess of atheromatous lesion formation [5, 42].
To date, several studies have shown that consumption of
flavonoid- and anthocyanin-rich diets helps to lower LDL-C
and TG levels and that this effect might be secondary to
reduced secretion of apo B-100 and very-low-density lipo-
protein (VLDL) packaging [45]. Besides, phenolic acids such
as gallic acid have been reported to enhance the expression of
LDL receptor and apo B-100 in hepatocytes [6]. Finally, diets
rich in anthocyanins and other types of phenolics are known
to protect against insulin resistance and obesity, which are
common features in the ethiopathogenesis of type 2 diabetes,
metabolic syndrome, and fatty liver disease [36].
Vascular inflammation, a primary event in the patho-
genesis of atherosclerosis [20], usually is characterized by
overexpression of CRP and cellular adhesion molecules
such as VCAM-1 and ICAM-1 [21, 27]. A large body of
data has indicated the protective effects of flavonoids
against vascular inflammation. These protective effects are
exerted via different mechanisms including scavenging of
reactive oxygen species, upregulation of antioxidant
enzymes, downregulation of inflammatory transcription
factors and cytokines, amelioration of endothelial function,
and enhancement of nitric oxide (NO) bioavailability [13].
In addition, anthocyanins and fruit juices rich in these
phytochemicals can interact with CAMs, suppress the
tumor necrosis factor-alpha (TNFa)-induced expression of
VCAM-1, and downregulate both the surface expression
and the release of ICAM-1 [5, 17, 26].
Study Limitations
The current study was limited in a number of ways that
deserve careful attention: First, the study population was
relatively small, and this could be regarded as the main
reason why significant between-group differences for many
of the biochemical parameters assessed in this study were
not detected. Second, the current trial was subject to
potential bias due to the lack of blinding and placebo
controlling. Third, the supplementation period in the cur-
rent trial was 6 weeks. This period may not have been
sufficient for detection of significant differences in the
circulating levels of lipoproteins and inflammatory factors.
Finally, it would be ideal to standardize CM intake based
on phytochemicals such as anthocyanins and flavonoids
rather than on crude fruit weight. To this end, it is neces-
sary to undertake phytochemical analysis of CM fruit.
Conclusions
In summary, findings from the current trial showed a trend
toward amelioration of lipid profile, apolipoprotein status,
and vascular inflammation. These findings provide addi-
tional evidence for the cardiovascular health benefits of
Cornus spp. Future large-scale trials are warranted to verify
the current findings in larger populations and over longer
periods of supplementation.
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